Back
Mersana Therapeutics Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
28
MRSN
Mersana Therapeutics
Last Price:
$0.31
Seasonality Move:
-7.32%
7 Day Trial
ALL ACCESS PASS
$
7
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRSN is experiencing slight selling pressure.
Mersana Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.36 | Sell |
| 20-day SMA: | 0.36 | Sell |
| 50-day SMA: | 0.4 | Sell |
| 200-day SMA: | 1.31 | Sell |
| 8-day EMA: | 0.35 | Sell |
| 20-day EMA: | 0.36 | Sell |
| 50-day EMA: | 0.45 | Sell |
| 200-day EMA: | 1.25 | Sell |
Mersana Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 41.86 | Sell |
| Chaikin Money Flow: | -780111 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.3 - 0.38) | Sell |
| Bollinger Bands (100): | (0.2 - 1.22) | Sell |
Mersana Therapeutics Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Mersana Therapeutics Stock
Is Mersana Therapeutics Stock a Buy?
-
Mersana Therapeutics share price is 0.32 while MRSN 8-day simple moving average is 0.36, which is a Sell signal.
-
The stock price of MRSN is 0.32 while Mersana Therapeutics 20-day SMA is 0.36, which makes it a Sell.
-
Mersana Therapeutics 50-day simple moving average is 0.40 while MRSN share price is 0.32, making it a Sell technically.
-
MRSN stock price is 0.32 and Mersana Therapeutics 200-day simple moving average is 1.31, creating a Sell signal.
MRSN Technical Analysis vs Fundamental Analysis
Sell
28
Mersana Therapeutics (MRSN)
is a Sell
Is Mersana Therapeutics a Buy or a Sell?
-
Mersana Therapeutics stock is rated a SellThe current Mersana Therapeutics [MRSN] share price is $0.32. The Score for MRSN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Mersana Therapeutics Stock Info
Market Cap:
39.7M
Price in USD:
0.32
Share Volume:
2M
Mersana Therapeutics 52-Week Range
52-Week High:
2.88
52-Week Low:
0.26
Sell
28
Mersana Therapeutics (MRSN)
is a Sell
Mersana Therapeutics Share Price Forecast
-
What is the Mersana Therapeutics stock price today?The Mersana Therapeutics stock price is 0.32 USD today.
-
Will MRSN stock go up or go down?Mersana Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Mersana Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mersana Therapeutics is overvalued.
Is Mersana Therapeutics Stock a Buy?
-
Mersana Therapeutics share price is 0.32 while MRSN 8-day exponential moving average is 0.35, which is a Sell signal.
-
The stock price of MRSN is 0.32 while Mersana Therapeutics 20-day EMA is 0.36, which makes it a Sell.
-
Mersana Therapeutics 50-day exponential moving average is 0.45 while MRSN share price is 0.32, making it a Sell technically.
-
MRSN stock price is 0.32 and Mersana Therapeutics 200-day simple moving average is 1.25, creating a Sell signal.
Fundamental Analysis of Mersana Therapeutics
Is Mersana Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.16 per share, and an increase next year of $0.11 per share.
Technical Analysis of Mersana Therapeutics
Should I short Mersana Therapeutics stock?
-
MRSN Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Mersana Therapeutics is a Sell
-
Mersana Therapeutics Relative Strength Index (RSI) is 41.86, which suggest Mersana Therapeutics is oversold
-
The Bollinger Bands (25) for Mersana Therapeutics is (0.3 - 0.38), which suggest Mersana Therapeutics is a Sell
-
The Bollinger Bands (100) for Mersana Therapeutics is (0.2 - 1.22), which suggest Mersana Therapeutics is a Sell
* Mersana Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.